APUS Latest Press Releases

-- May 5, 2026 --

Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lokahi Therapeutics to Advance Apitox Program Business Wire 2:07 PM

-- April 26, 2026 --

APUS Investors Have Opportunity to Join Apimeds Pharmaceuticals US, Inc. Fraud Investigation with the Schall Law Firm Globe Newswire 8:12 PM

-- April 16, 2026 --

Apimeds Pharmaceuticals Investor News: Rosen Law Firm Encourages Apimeds Pharmaceuticals US, Inc. Investors to Inquire About Securities Class Action Investigation - APUS Business Wire 10:14 AM

-- April 15, 2026 --

Rosen Law Firm Encourages Apimeds Pharmaceuticals US, Inc. Investors to Inquire About Securities Class Action Investigation - APUS Business Wire 6:35 PM

-- March 25, 2026 --

Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc. Globe Newswire 7:00 AM

-- March 24, 2026 --

Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery Business Wire 8:30 AM

-- February 11, 2026 --

Apimeds Pharmaceuticals and Lokahi Therapeutics Announce FDA Type C Meeting Scheduled for LT-100 (Apitox) Business Wire 4:51 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software